El síndrome deficitario: Un dominio dentro de la esquizofrenia

Actas Espanolas de Psiquiatria

Volumn 26, Issue 3, 1998, Pages 180-186

  Arango, C ^a,b   Kirkpatrick, B ^a   Buchanan, R W ^a   Carpenter Jr , W T ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b MPRC   (United States)

Author keywords

Deficit syndrome; Negative symptoms; Pathophysiology; Schizophrenia

Indexed keywords

COGNITIVE DEFECT; HUMAN; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA;

COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 2842597989     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Strauss JS, Carpenter WT, Bartko JJ. The diagnosis and understanding of schizophrenia. Part II: speculations on the process that underlie schizophrniac symptoms and signs. Schizophr Bull 1974;11:61-9.
2. Carpenter WT Jr, Strauss JS. The prediction of outcome in schizophrenia. IV: Eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991;179: 517-25.
3. Liddle PF. The symptoms of chronic schizophrenia: A reexamination of the positive-negative dichotomy. Br J Psychiatry 1987a;151:145-51.
4. Arndt S, Alliger RJ, Andreasen NC. The distinction of positive and negative symptoms: the failure of a two-dimensional model. Br J Psychiatry 1991;158;317-22.
5. Peralta V, de León J, Cuesta MJ. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. Br J Psychiatry 1992; 161:335-43.
6. Buchanan RW, Carpenter WT Jr. Domains of psychopathology. An approach to the reduction of heterogeneity in schizophrenia. J Nerv Ment Disease 1994; 182:193-204.
7. Karayiorgou M, Gogos JA. Dissecting the genetic complexity of schizophrenia. Mol Psychiatry 1997; 2:211-23.
8. Carpenter WT Jr, Buchanan RW. Domains of psychopathology relevant to the study of etiology and treatment in schizophrenia. En: Schulz, SC; Tamminga, CA (eds) Schizophrenia. Scientific progress. Nueva York, Oxford Press, 1989.
9. Kirkpatrick B, Buchanan RW. The neural basis of the deficit syndrome of schizophrenia. J Nerv Ment Dis 1990;178:545-55.
10. Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Tamminga C, Wood F. Strong inference, theory testing, and the neuroanatomy of schizophrenia. Arch Gen Psychiatry 1993;50:825-31.
11. Crow TJ. The two-syndrome concept: origins and current status. Schizophr Bull 1985;11:571-486.
12. Andreasen NC, Olsen SA. Negative vs. positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982;39:789-94.
13. Liddle PF, Barnes TR, Morris D, Haque S. Three syndromes in chronic schizophrenia. Br J Psychiatry Suppl 1989;7:119-22.
14. Carpenter WT Jr, Heinrichs DW, Wagman AMI. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988;145:578-83.
15. Kraepelin E. Dementia praecox and paraphrenia. Edimburgh, Scotland: E.S. Livignston, 1919.
16. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr. The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989;30:119-24.
17. Fenton WS, McGlashan TH. Testing systems for assessment of negative symptoms in schizophrenia. Arch Gen Psychiatry 1992;49:179-84.
18. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl 1989;7:49-58.
19. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
20. Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes, II: positive and negative symptoms and long-term course. Arch Gen Psychiatry 1991;48:978-86.
21. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT Jr. Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Res 1993;47:47-56.
22. McGlashan TH, Fenton WS. Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophr Bull 1993;19:71-84.
23. Kirkpatrick B, Amador XF, Yale SA, Bustillo JR, Buchanan RW, Tohen M. The deficit syndrome in the DSM-IV field trial. Depressive episodes and persecutory beliefs. Schizophr Res 1996a;20:79-90.
24. Kirkpatrick B, Amador XF, Flaum M, Yale SA, Gorman JM, Carpenter WT Jr, Tohen M, McGlashan T. The deficit syndrome in the DSM-IV field trial: Alcohol and other drug abuse. Schizophr Res 1996b;20:76-68.
25. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT Jr. Depressive symptoms and the deficit syndrome of schizophrenia. J Nerv Ment Dis 1994;182:452-5.
26. Carpenter WT Jr. The deficit syndrome (Editorial). Am J Psychiatry 1994;151:327-9.
27. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT Jr. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry 1990;147:290-4.
28. Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT Jr. Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 1993;150:59-65.
29. Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT Jr. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994;15:20-6.
30. Meltzer HY. Clozapine: is another view valid? (Editorial). Am J Psychiatry 1995;152:821-5.
31. Carpenter WT Jr, Conley RR, Buchanan RW, Breier A, Tamminga CA. Patient response and resource management: another view of clozapine treatment of schizophrenia. Am J Psychiatry 1995;152:827-32
32. Kopelowicz A, Liberman RP, Mintz J, Zarate R. Comparison of efficacy of social skills training for the deficit and nondefict negative symptoms in schizophrenia. Am J Psychiatry 1997;154:424-5.
33. Fenton WS, McGlashan TH, Victor BJ, Blyler CR. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry 1997;154:199-204.
34. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992;49:522-30.
35. Lahti AC, Holcomb HH, Carpenter WT, Zhao M, Buchanan RW, Tamminga CA. Blood flow activation differences during an auditory task in schizophrenic patients with and without primary negative symptoms. Schizophr Research 1997;24:167.
36. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992;160:179-86.
37. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 1994;51:804-11.
38. Liddle PF. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 1987b;17:49-57.
39. Fenton WS, Wyatt RJ, McGlashan TH. Risk factors for spontaneous dyskinesia in schizophrenia. Arch Gen Psychiatry 1994;51:643-50.
40. Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Moran M, Hartley J. Association of abnormal smooth pursuit eye movement with the deficit syndrome in schizophrenic patients. Am J Psychiatry 1996;153:1158-65.
41. Thaker G, Kirkpatrick B, Buchanan RW, Ellsberry R, Lahti A, Tamminga C. Oculomotor abnormalities and their clinical correlates in schizophrenia. Psychopharmacol Bull 1989;25:491-7.
42. Bustillo JR, Thaker G, Buchanan RW, Moran M, Kirkpatrick B, Carpenter WT Jr. Visual information-processing impairments in deficit and nondeficit schizophrenia. Am J Psychiatry 1997;154:647-54.
43. Dollfus S, Ribeyre JM, Petit M. Family history and deficit form in schizophrenia. Eur Psychiatry 1996;11: 260-7.
44. Waltrip RW 2nd, Buchanan RW, Carpenter WT Jr, Kirkpatrick B, Summerfelt A, Breier A, Rubin SA, Carbone KM. Borna disease virus antibodies and the deficit syndrome of schizophrenia. Schizophr Res 1997;23:253-8.
45. Ribeyre JM, Lesieur P, Varoquaux O, Dollfus S, Pays M, Petit M. A comparison of plasma homovanilic acid in the deficit and nondeficit subtypes of schizophrenia. Biol Psychiatry 1994;36:230-6.
46. Nibuya M, Kanba S, Sekiya U, Suzuki E, Matsuo Y, Kinoshita N, Shintani F, Yagi G, Asai M. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement. Biol Psychiatry 1995;38:50-6.